Sponsor

Capital Medical University

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Capital Medical University appears in 69 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials69
Recruiting shown10
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
RAPART in Locally Advanced Non-small Cell Lung Cancer PatientsNCT07164885 · lead sponsor · 2025-02-17
RECRUITING
App and Body Fat Scale in the Management of Overweight PatientsNCT05866107 · lead sponsor · 2023-10-31
RECRUITING
Integrated Diagnosis and Treatment of CKD on OutcomesNCT05242055 · lead sponsor · 2022-02-01
RECRUITING
Detection of Alzheimer's Disease (AD)-Related Seeds for AD DiagnosisNCT04850053 · lead sponsor · 2020-08-26
RECRUITING
Study on Biomarkers for Early Diagnosis of Alzheimer's DiseaseNCT04575337 · lead sponsor · 2020-05-28
RECRUITING
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's DiseaseNCT05020106 · lead sponsor · 2018-09-01
RECRUITING
The Chinese Familial Alzheimer's NetworkNCT03657732 · lead sponsor · 2005-01-10
RECRUITING
China Cognition and Aging StudyNCT03653156 · lead sponsor · 2000-01-01
RECRUITING
Context-Guided Personalized iTBS for DepressionNCT07743398 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Personalized Accelerated iTBS Versus Sham for Major Depressive DisorderNCT07843875 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Exercise Intervention for Breast Cancer Patients With SarcopeniaNCT07732101 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Effects of Functional Oils on Obesity With Mild Cognitive ImpairmentNCT07690384 · lead sponsor · 2026-07-01
NOT_YET_RECRUITING
Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant PopulationsNCT07562477 · lead sponsor · 2026-05-10
NOT_YET_RECRUITING
Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cancer Undergoing ChemotherapyNCT07495358 · lead sponsor · 2026-04-15
NOT_YET_RECRUITING
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer DiseaseNCT07600996 · lead sponsor · 2026-03-01
COMPLETED
Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 DiabetesNCT07472855 · lead sponsor · 2025-06-01
COMPLETED
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPDNCT06779344 · lead sponsor · 2025-01-13
NOT_YET_RECRUITING
Remote Ischemic Conditioning for the Treatment of Diabetic Kidney DiseaseNCT06654921 · lead sponsor · 2025-01-01
NOT_YET_RECRUITING
Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLCNCT06613308 · lead sponsor · 2024-09-25
UNKNOWN
Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in BeijingNCT06489990 · lead sponsor · 2024-08-01
NOT_YET_RECRUITING
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension TreatmentNCT06361823 · lead sponsor · 2024-05-01
UNKNOWN
The Ketogenic Diet in the Treatment of Alzheimer's DiseaseNCT06681948 · lead sponsor · 2024-02-23
COMPLETED
Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil LevelsNCT05059873 · lead sponsor · 2023-03-05
TERMINATED
Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's DiseaseNCT05670912 · lead sponsor · 2022-10-01
TERMINATED
Hypofractionation With Simultaneous Integrated Boost for Early Breast CancerNCT04913532 · lead sponsor · 2021-06-22
COMPLETED
The Antihypertensive Effect of Remote Ischemic Conditioning (RIC-HTN).NCT04915313 · lead sponsor · 2021-06-15
COMPLETED
A Trial of Procalcitonin in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseNCT04682899 · lead sponsor · 2021-02-01
UNKNOWN
Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's DiseaseNCT05269173 · lead sponsor · 2020-10-29
COMPLETED
Characteristic and Modulation of Gut Microbiota on the Consequences of PregnancyNCT04190511 · lead sponsor · 2019-12-10
COMPLETED
Effects of Dietary and Weight Management on Pregnancy Outcomes in Mobile Medical PlatformNCT04989634 · lead sponsor · 2019-07-01
UNKNOWN
Safety and Feasibility of Remote Ischemic Conditioning on Prehypertension and Early-stage HypertensionNCT04254432 · lead sponsor · 2019-06-30
UNKNOWN
Medical Nutrition Therapy Combined With TPF-DM in Pregnant Women With Gestational Diabetes MellitusNCT03957603 · lead sponsor · 2019-05-16
COMPLETED
Endovascular Stenting Treatment for Patients With Internal Jugular Vein StenosisNCT03373292 · lead sponsor · 2018-01-01
UNKNOWN
Combination of Immunotherapy and Hyperthermia in Advanced Malignant MesotheliomaNCT03393858 · lead sponsor · 2017-12-01
TERMINATED
Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment ScalesNCT03273179 · lead sponsor · 2017-06-01
UNKNOWN
Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDDNCT03131050 · lead sponsor · 2017-03-15
COMPLETED
Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLCNCT03360630 · lead sponsor · 2016-11-01
COMPLETED
Lifestyle Intervention in Pregnant Women With PCOSNCT04216485 · lead sponsor · 2016-10-01
COMPLETED
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsNCT02583828 · lead sponsor · 2015-06-01
COMPLETED
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung CancerNCT02288026 · lead sponsor · 2014-09-01
UNKNOWN
Influencing Factors of Intracranial Hypertension in Patients With Bilateral Transverse Sinus StenosisNCT04492332 · lead sponsor · 2014-01-01
COMPLETED
Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionNCT01824433 · lead sponsor · 2013-03-07
COMPLETED
A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic PlaquesNCT02305862 · lead sponsor · 2013-01-01
UNKNOWN
Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early ImprovementNCT01458626 · lead sponsor · 2012-11-14
COMPLETED
The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled TrialNCT02191124 · lead sponsor · 2011-06-01
COMPLETED
Dietary and Lifestyle Interventions in Obese Pregnant WomenNCT02095028 · lead sponsor · 2011-04-01
COMPLETED
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:NCT01263080 · lead sponsor · 2010-11-01
COMPLETED
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis PatientsNCT01455974 · lead sponsor · 2010-10-01
COMPLETED
Deep-brain Magnetic Stimulation (DMS) in the Treatment of Major Depressive DisorderNCT02184221 · lead sponsor · 2010-05-01
COMPLETED
Simvatstatin Used to Treat Pulmonary HypertensionNCT00538044 · lead sponsor · 2009-01-01
UNKNOWN
Risperidone Maintenance Treatment in SchizophreniaNCT00848432 · lead sponsor · 2002-12-01
COMPLETED
Effectiveness of Bariatric Surgery for NAFLD/NASHNCT04366999 · collaborator · 2020-04-21
RECRUITING
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint InhibitorsNCT06950697 · collaborator · 2019-01-01
RECRUITING
Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With AlbuminuriaNCT07849348 · collaborator · 2026-09-01
NOT_YET_RECRUITING
Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang DeficiencyNCT07698548 · collaborator · 2026-08-01
NOT_YET_RECRUITING
Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell CarcinomaNCT07618793 · collaborator · 2026-06-01
NOT_YET_RECRUITING
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral HemorrhageNCT06760078 · collaborator · 2024-12-31
NOT_YET_RECRUITING
Treatable Traits of Severe AsthmaNCT06811740 · collaborator · 2024-01-01
ENROLLING_BY_INVITATION
Early COPD for China Pulmonary Health Study Stage IINCT05028985 · collaborator · 2021-01-01
UNKNOWN
Intestinal Flora and Major Depressive DisordersNCT04347577 · collaborator · 2020-04-10
UNKNOWN

Drugs studied in this sponsor's trials

18 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Capital Medical University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
mirtazapine3
placebo3
semaglutide2
amlodipine1
duloxetine1
escitalopram1
finerenone1
fluoxetine1
mirtazapine RxCUI 15996 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 3 trials semaglutide RxCUI 1991302 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials amlodipine RxCUI 17767 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial duloxetine RxCUI 72625 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial escitalopram RxCUI 321988 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial finerenone RxCUI 2562811 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial fluoxetine RxCUI 4493 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial folic acid RxCUI 4511 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial haloperidol RxCUI 5093 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial letrozole 2.5 MG RxCUI 316135 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paroxetine RxCUI 32937 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial prednisone RxCUI 8640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial risperidone RxCUI 35636 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial risperidone Oral Solution RxCUI 373790 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial scopolamine RxCUI 9601 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial simvastatin RxCUI 36567 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial venlafaxine RxCUI 39786 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor51
collaborator18
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.